Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von NightmareKing 

Teladoc Health Inc diskutieren

Teladoc Health Inc

WKN: A14VPK / Symbol: TDOC / Name: Teladoc Health / Aktie / Anbieter & Dienstleistungen / Mid Cap /

11,88 €
0,30 %

Sell Teladoc Health Inc

Buy Teladoc Health Inc

Einschätzung Buy
Rendite (%) -46,72 %
Kursziel 33,76
Veränderung
Endet am 06.03.24

Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $40.00 to $36.00. They now have a "buy" rating on the stock.
Ratings data for TDOC provided by MarketBeat

Einschätzung Buy
Rendite (%) -26,51 %
Kursziel 24,55
Veränderung
Endet am 25.10.24

Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $35.00 to $26.00. They now have an "outperform" rating on the stock.
Ratings data for TDOC provided by MarketBeat

Einschätzung Buy
Rendite (%) -27,80 %
Kursziel 28,38
Veränderung
Endet am 25.10.24

Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at Royal Bank of Canada from $35.00 to $30.00. They now have an "outperform" rating on the stock.
Ratings data for TDOC provided by MarketBeat

Einschätzung Buy
Rendite (%) -39,21 %
Kursziel 23,81
Veränderung
Endet am 03.01.25

Teladoc Health, Inc. (NYSE: TDOC) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $26.00 price target on the stock.
Ratings data for TDOC provided by MarketBeat

Einschätzung Buy
Rendite (%) -17,73 %
Kursziel 23,11
Veränderung
Endet am 21.02.25

Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at Piper Sandler from $30.00 to $25.00. They now have an "overweight" rating on the stock.
Ratings data for TDOC provided by MarketBeat

Einschätzung Buy
Rendite (%) -17,01 %
Kursziel 23,12
Veränderung
Endet am 21.02.25

Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at Barclays PLC from $26.00 to $25.00. They now have an "overweight" rating on the stock.
Ratings data for TDOC provided by MarketBeat

Einschätzung Buy
Rendite (%) -17,01 %
Kursziel 23,12
Veränderung
Endet am 21.02.25

Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at Royal Bank of Canada from $30.00 to $25.00. They now have an "outperform" rating on the stock.
Ratings data for TDOC provided by MarketBeat

Einschätzung Buy
Rendite (%) -15,63 %
Kursziel 20,30
Veränderung
Endet am 28.02.25

Teladoc Health, Inc. (NYSE: TDOC) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $22.00 price target on the stock.
Ratings data for TDOC provided by MarketBeat

Einschätzung Buy
Rendite (%) -4,42 %
Kursziel 18,73
Veränderung
Endet am 26.04.25

Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at Barclays PLC from $25.00 to $20.00. They now have an "overweight" rating on the stock.
Ratings data for TDOC provided by MarketBeat

Einschätzung Buy
Rendite (%) -3,30 %
Kursziel 16,82
Veränderung
Endet am 26.04.25

Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at Royal Bank of Canada from $25.00 to $18.00. They now have an "outperform" rating on the stock.
Ratings data for TDOC provided by MarketBeat

Einschätzung Buy
Rendite (%) -2,45 %
Kursziel 19,62
Veränderung
Endet am 26.04.25

Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $26.00 to $21.00. They now have an "outperform" rating on the stock.
Ratings data for TDOC provided by MarketBeat